Alx Oncology Holdings Inc. (ALXO)
Market Closed
1 Sep, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary $
1. 98
+0.05
+2.5907%
$
259.71M Market Cap
- P/E Ratio
- Div Yield
1.44M Volume
-3.52 Eps
$ 1.93
Previous Close 
Want to track ALXO and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
| | | - | - |
ALXO Earnings Reports FAQ
What is the earnings per share (EPS) for ALXO?
The current EPS is -3.52.
What is the company's earnings growth rate?
Alx Oncology Holdings Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
Alx Oncology Holdings Inc has not announced its next earnings release date.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Alx Oncology Holdings Inc are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ALXO at this time, as Alx Oncology Holdings Inc has no recent EPS data to calculate it.
